Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group

Molecular biomarker testing is the standard of care for non–small cell lung cancer (NSCLC) patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean Molecular Pathology Study Group co-published a molecular testing guideline which contained almost all known genetic changes th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sunhee, Shim, Hyo Sup, Kim, Tae Jung, Choi, Yoon-La, Kim, Wan Seop, Shin, Dong Hoon, Kim, Lucia, Park, Heae Surng, Lee, Geon Kook, Lee, Chang Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141968/
https://www.ncbi.nlm.nih.gov/pubmed/33966368
http://dx.doi.org/10.4132/jptm.2021.03.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141968/
https://www.ncbi.nlm.nih.gov/pubmed/33966368
http://dx.doi.org/10.4132/jptm.2021.03.23

Ejemplares similares